Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Treatment with doxycycline to promote the healing of chronic venous ulcer and markers of chronic venous insufficiency. A randomised controlled trial.
ISRCTN ISRCTN28389872
ClinicalTrials.gov identifier
Public title Treatment with doxycycline to promote the healing of chronic venous ulcer and markers of chronic venous insufficiency. A randomised controlled trial.
Scientific title
Acronym N/A
Serial number at source N0013146069
Study hypothesis 1. Is haemosiderin a reliable marker for venous insufficiency?
2. Does the inhibition of matrix matalloproteinase play any role in the healing of ulcer?
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cardiovascular: Venous ulcers
Participants - inclusion criteria Not provided at time of registration
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/09/2003
Anticipated end date 01/12/2007
Status of trial Completed
Patient information material
Target number of participants 60 patients will be recruited from the venous ulcer out patients clinic at St Thomas' Hospital.
Interventions Patients will be randomised into either treatment or control group. Each group will be matched according to ulcer size. The treatment group will take 2 daily 100mg of doxycycline and the patients in the control group will take matched placebo tablets. A biopsy from the ulcer will be obtained before the start of the study and at 8 weeks. Sample will be used to determine the (Matrix Metalloproteinase) MMPs level.
Primary outcome measure(s) Ulcer sizes, complete or incomplete healing.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Guy's and St. Thomas' NHS Foundation Trust (UK)
Own Account - NHS R&D Support Funding
Trial website
Publications
Contact name Prof  Kevin  Burnand
  Address Guy's and St Thomas' NHS Foundation Trust
General, Vascular and Colorectal Surgery Department
F01 North Wing
St Thomas' Hospital, Lambeth Palace Road
  City/town London
  Zip/Postcode SE1 7EH
  Country United Kingdom
  Tel +44 (0)20 7188 2570
  Fax +44
  Email Kevin.burnand@kcl.ac.uk
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 07/04/2011
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central